The effect of continuing versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: study protocol for a multi-centric open-label randomised controlled trial

被引:0
作者
Satyajeet Misra
Satyen Parida
Raj Sahajanandan
Bikram Kishore Behera
Muthapillai Senthilnathan
Ramamani Mariappan
Tony Thomson Chandy
机构
[1] AIIMS Bhubaneswar,
[2] JIPMER Puducherry,undefined
[3] CMC Vellore,undefined
来源
Trials | / 23卷
关键词
ACE inhibitors; ARB; Acute kidney injury; Angioedema; Complications; Mortality; Outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 45 条
[1]  
Weiser TG(2008)An estimation of the global volume of surgery: a modelling strategy based on available data Lancet 372 139-144
[2]  
Regenbogen SE(2010)Perioperative cardiac assessment and rationale for use of beta-blockers Ind Heart J 62 158-167
[3]  
Thompson KD(2017)Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort Anesthesiology 126 16-27
[4]  
Chopra HK(2015)To stop or not? Anesth Analg 120 1413-1419
[5]  
Sambi RS(2014)The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery Anesth Analg 119 1053-1063
[6]  
Krishna CK(2017)To stop or not? Withholding anti-hypertensive therapy before surgery is not safe J Cardiothorac Vasc Anesth 31 e79-e99
[7]  
Roshanov PS(2016)High postoperative blood pressure after cardiac surgery is associated with acute kidney injury and death J Cardiothorac Vasc Anesth 30 1562-1570
[8]  
Rochwerg B(2018)Restrictive versus liberal fluid therapy for major abdominal surgery N Engl J Med 378 2263-2274
[9]  
Patel A(2012)KDIGO clinical practice guideline for acute kidney injury Kidney Int Suppl 2 1-138
[10]  
Mets B(1979)A multiple testing procedure for clinical trials Biometrics 35 549-556